BioMagnetic Solutions

We develop high value therapeutic and diagnostic bio medical applications based on finding needles (immune cells; tumor cells; pathogens) in haystacks.

  • Stage Product In Development
  • Industry Biotechnology
  • Location State College, PA, US
  • Currency USD
  • Founded 2012
  • Employees 5
  • Website BioMagneticSolutions.com

Company Summary

Goal: To be world leader in bio-magnetic separations via top tier tools - advanced proprietary magnetic nanoparticles and novel high gradient magnetic separators. Applications: high value medical, biopharma and industrial separations, e.g. isolation of: tumor cells, stem cells, specific immune cells, pathogens and key therapeutic macromolecules. Research tools go to market May 2014. Corporate R&D-marketing partner route for automated systems.

Team

  • Paul Liberti
    CEO, CSO, President and Chairman of the Board

    Professor Jefferson Medical College (15 y) intnl rep for research in Immunity, NIH funded research program, Director NIAID post doctoral program Allergy/Immunology. Founded and managed (16y) Immunicon Corp, Huntingdon Valley Pa, raised 15 million VC, 30 million Corporate partnerships (Serono, Beckman, B-D, Eastman Kodak) brought Johnson & Johnson in as a marketing partner for cancer test invented and developed by Liberti, resp for IP and strategy

  • Paul Liberti
    COO, VP of Business Development/Marketing

    MBA, MS Econ, PhD (abd), fluent in French and Italian, Project and Market analyst for Ben Franklin Partnership, Commonwealth of Pa. Consultant in Business Development to Immunicon re internactions with Gerbet, BioMerieux, Institute Pasteur. Partner Italian wine import business. Founder/organizer of Penn State Wine Festival (a major fund raiser of Penn State PBS). Co-founder of BMS performing feasibililty expts and first round of startuip funds.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free